Allergy Related Medicines Recalls And Updates

Medicine recalls and side affects.

For email alerts directly to your mail box email enquiries@bffa.life adding medicine recalls, food recalls, or both.

27/04/2022 Revised SPC: Marvelon and Mercilon (ethinylestradiol/desogestrel) Tablets

SPCs updated to warn that exogenous estrogens may induce or exacerbate symptoms of hereditary and acquired angioedema.

https://www.medicines.org.uk/emc/product/1359/smpc

source text NICE

26/04/2022 Withdrawal of marketing authorisation application of Neffy (epinephrine nasal spray) for emergency treatment of severe allergic reactions, including anaphylaxis.

Reasons for withdrawal included concerns from the CHMP that it could not be confirmed nasal absorption in patients with acute anaphylaxis was adequate, and whether the proposed dose could achieve the expected clinical outcome.

Source: European Medicines Agency

see link

https://www.ema.europa.eu/en/medicines/human/withdrawn-applications/neffy

12/04/2022 Olopatadine USV 1mg/ml Eye Drops, Solution, for seasonal allergic conjunctivitis.

Follow link to see more

07/04/2022 IMVAGGIS 0.03 mg Pessary

Exogenous estrogens may induce or exacerbate symptoms of hereditary and acquired angioedema.

See link for more details

https://www.medicines.org.uk/emc/product/10435

07/04/2022 FemSeven Conti 50 micrograms/7 micrograms/24 hours, transdermal patch

Exogenous estrogens may induce or exacerbate symptoms of hereditary and acquired angioedema.

See link for more details

https://www.medicines.org.uk/emc/product/12069

07/04/2022 Arikayce Liposomal 500mg serious side effect – may be associated with development of allergic lung condition – allergic alveolitis

31/12/2021 Dermaved is recalling the above product from patients due to presence of clobetasol propionate

(0.001% Company led medicines recall: Dermaved Sensitive Cream (unlicensed medicine), CLMR (21)A/09w/w).

Used primarily for psoriasis and eczema.

To see more information, follow link

21/12/2021 Error relating to the stated alcohol content for batches of Benylin Chesty Coughs Original (P) and Benylin Chesty Coughs Non-Drowsy (GSL), supplied by McNeil Products Limited

Class 4 Medicines defect information: Benylin Chesty Coughs Original (P) and Benylin Chesty Coughs Non-Drowsy (GSL), EL(21)A/39

30/11/2021 Error relating to the wording on the outer carton label for Mometasone Furoate 50 Microgram / Dose Nasal Spray, supplied by PilsCo Ltd.

Class 4 Medicines Defect Information: Mometasone Furoate 50 Microgram / Dose Nasal Spray, Suspension, PilsCo Ltd, EL (21)A/33

16/06/2021 Recall Medicine 

01/03/20221 Recall: Easyhaler Salbutamol Sulfate 100 micrograms per actuation/200 micrograms per actuation inhalation powder, EL (21)A/06

Page summary:
Orion Corporation T/A Orion Pharma (UK) Ltd are recalling specific batches as a precautionary measure due to an issue related to moulding defects in the bulk chambers where the inhalation powder is stored.

Change made:
First published.

Time updated:
11:06am, 1 March 2021

If you have any questions about the medical content in this email, contact MHRA on info@mhra.gov.uk

© All material on these pages, including without limitation text, logos, icons, photographs, and all other artwork is copyright material of British Food Allergy Awareness, unless otherwise stated.